Glaucoma neuroprotection with BDNF on the level of retinal and primary visual cortex
2016/23/N/NZ7/02555
Keywords
Descriptors
- NZ7_4: Prewencja populacyjna
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Biologii Doświadczalnej im. M. Nenckiego PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 12 – announced on 2016-09-15
- Amount awarded
- 150 000 PLN
- Project start date
- 2017-08-29
- Project end date
- 2021-02-27
- Project duration
- 42 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- 55-calowy monitor z zakrzywionym ekranem typu OLED. Cost: 7 200 PLN
Information in the final report
Publication in academic press/journals (1)
-
Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
- Authors:
- Anna Wójcik-Gryciuk, Olga Gajewska-Woźniak, Katarzyna Kordecka, Paweł M. Boguszewski, Wioletta Waleszczyk, Małgorzata Skup
- Academic press:
- International Journal of Molecular Sciences (year: 2020, volume: 17, pages: 15), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms21176262 – link to the publication